fig3
![EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAF<sup>V600E</sup> mutation: a case report and review of literature](https://image.oaes.cc/069de34b-8bbb-463f-9756-7f0b498e6e6a/4425.fig.3.jpg)
Figure 3. The mutations detected at different timepoints available from tissue or liquid biopsies.
Figure 3. The mutations detected at different timepoints available from tissue or liquid biopsies.
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/